Posted by Michael Wonder on 20 Aug 2018
Companies report no signs of drug makers cutting prices, despite Trump pledge
17 August 2018 - Several companies that manage prescription drug benefits for insurers say they have not received any commitments from drug makers to lower list prices.
Express Scripts, Humana, MedImpact, Optum RX and Prime Therapeutics all wrote in letters to Sens. Elizabeth Warren (D-Mass) and Tina Smith (D-Minn.) that they have not received commitments from drug manufacturers to lower drug prices.
President Trump said earlier this summer that drug makers would soon announce "massive" and "voluntary" price cuts, but so far Merck is the only company to decrease the costs of some medicines.
Other drug makers have announced freezes of planned price increases for the remainder of the year.
